A 30-year-old patient with no comorbidities and stage IA Hodgkin’s lymphoma has successfully undergone a course of chemoradiotherapy | Medibuddy
1st April 2022

A 30-year-old patient with no comorbidities and stage IA Hodgkin’s lymphoma has successfully undergone a course of chemoradiotherapy

A 30-year-old patient with no comorbidities and stage IA Hodgkin’s lymphoma has successfully undergone a course of chemoradiotherapy. His 5-year survival rate is:

Select the SINGLE most appropriate option from the list below. Select ONE option only.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.